Critical role of c-Jun N-terminal kinase in regulating bFGF-induced angiogenesis in vitro

Journal of Biochemistry

Volumn 150, Issue 2, 2011, Pages 189-197

  Kaikai, Shen ^a   Yuchen, Sheng ^b   Lili, Ji ^a,c   Zhengtao, Wang ^a,c  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY   (China)

^c Shanghai R and D Centre for Standardization of Chinese Medicines   (China)

Author keywords

angiogenesis; bFGF; HUVECs; JNK; SAPK

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BASIC FIBROBLAST GROWTH FACTOR; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTHRACENES; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; GENE SILENCING; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 9; NEOVASCULARIZATION, PHYSIOLOGIC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UMBILICAL VEINS;

EID: 79961074438     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvr060     Document Type: Article

References (37)

1. Folkman, I. (2007) Angiogenesis: An organizing principle for drug discovery? Nat. Rev. Drug Discov. 6, 273-286
2. Jain, R.K. (2003) Molecular regulation of vessel maturation. Nat. Med. 9, 685-693 (Pubitemid 36749217)
3. Karamysheva, A.F. (2008) Mechanisms of angiogenesis. Biochemistry 73, 751-762
4. Dong, X., Han, Z.C., and Yang, R. (2007) Angiogenesis and antiangiogenic therapy in hematologic malignancies. Crit. Rev. Oncol. Hematol. 62, 105-118 (Pubitemid 46584811)
5. Cao, R., Brakenhielm, E., Pawliuk, R., Wariaro, D., Post, M.J., Wahlberg, E., and Leboulch, P. (2003) Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat. Med. 9, 604-613 (Pubitemid 36597108)
6. Son, M.J., Kim, J.S., Kim, M.H., Song, H.S., Kim, J.T., Kim, H., Shin, T., Jeon, H.J., Lee, D.S., Park, S.Y., Kim, Y.J., Kim, J.H., and Nam, D.H. (2006) Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model. Int. J. Oncol. 28, 53-59
7. Eichholz, A., Merchant, S., and Gaya, A.M. (2010) Anti-angiogenesis therapies: Their potential in cancer management. Onco. Targets Ther. 3, 69-82
8. Makino, T., Jinnin, M., Muchemwa, F.C., Fukushima, S., Kogushi-Nishi, H., Moriya, C., Igata, T., Fujisawa, A., Johno, T., and Ihn, H. (2010) Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways. Br. J. Dermatol. 162, 717-723
9. Im, H.J., Muddasani, P., Nataraian, V., Schmid, T.M., Block, J.A., Davis, F., van Wijnen, A.J., and Loeser, R.F. (2007) Basic fibroblast growth factor stimulates matrix metalloproteinase-13 via the molecular cross-talk between the mitogen activated protein kinases and protein kinase Cdelta pathways in human adult articular chondrocytes. J. Biol. Chem. 282, 11110-11121 (Pubitemid 47100793)
10. Flati, V., Pastore, L.I., Griffioen, A.W., Satijn, S., Toniato, E., D'Alimonte, I., Laglia, E., Marchetti, P., Gulino, A., and Martinotti, S. (2006) Endothelial cell anergy is mediated by bFGF through the sustained activation of p38-MAPK and NF-kappaB inhibition. Int. J. Immunopathol. Pharmacol. 19, 761-773 (Pubitemid 46145040)
11. Cross, T.G., Scheel-Toellner, D., Henriquez, N.V., Deacon, E., Salmon, M., and Lord, J.M. (2000) Serine/ thronine protein kinases and apoptosis. Exp. Cell Res. 256, 34-41 (Pubitemid 30211164)
12. Pearson, G., Robinson, F., Beers, G.T., Xu, B.E., Karandikar, M., Berman, K., and Cobb, M.H. (2001) Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr. Rev. 22, 153-183 (Pubitemid 32458157)
13. Reddy, K.B., Nabha, S.M., and Atanaskova, N. (2003) Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 22, 395-403 (Pubitemid 36791895)
14. Panka, D.J., Atkins, M.B., and Mier, J.W. (2006) Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma. Clin. Cancer Res. 12, 2371 s-2375 s
15. Pelikanova, T. (2007) Pathogenesis of diabetic retinopathy. Vnitr. Lek. 53, 498-505 (Pubitemid 46932787)
16. Peng, C.Y., Pan, S.L., Lee, K.H., Bastow, K.F., and Teng, C.M. (2008) Molecular mechanism of the inhibitory effct of KS-5 on bFGF-induced angiogenesis in vitro and in vivo. Cancer Lett. 263, 114-121
17. Pang, X., Yi, T., Yi, Z., Cho, S.G., Qu, W., Pinkaew, D., Fujise, K., and Liu, M. (2009) Morelloflavone a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways. Cancer Res. 69, 518-525
18. Lin, K.T., Lien, J.C., Chung, C.H., Kuo, S.C., and Huang, T.F. (2010) A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis. Eur. J. Pharmacol. 630, 53-60
19. Rousseau, S., Houle, F., Landry, J., and Huot, J. (1997) p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15, 2169-2177 (Pubitemid 27493906)
20. Shin-ichiro, M., Yoshino, M., and Keijiro, S. (2008) Jun N-Terminal kinase inhibitor blocks angiogenesis by blocking VEGF secretion and an MMP pathway. J. Atheroscler. Thrornb. 15, 69-74
21. Wu, J.C., Yan, H.C., Chen, W.T., Chen, W.H., Wang, C.J., Chi, Y.C., and Kao, W.Y. (2008) JNK signaling pathway is required for bFGF-mediated surface cadherin downregulation on HUVEC. Exp. Cell Res. 314, 421-429
22. Marin, V., Kaplanski, G., Gres, S., Farnarier, C., and Bongrand, P. (2001) Endothelial cell culture: Protocol to obtain and cultivate human umbilical endothelial cells. J. Immunol. Methods 254, 183-190 (Pubitemid 32530758)
23. Hong, B.Z., Park, S.A., Kim, H.N., Ma, T.Z., Kim, H.G., Kang, H.S., Kim, H.G., and Kwak, Y.G. (2009) Basic fibroblast growth factor increases intracellular magnesium concentration through the specific signaling pathways. Mol. Cells 28, 13-17
24. D'Amato, R.J., Loughnan, M.S., Flynn, E., and Flokman, J. (1994) Thalidomide is an inhibitor of angiogenesis. Proc. Natl Acad. Sci. USA 91, 4082-4085 (Pubitemid 24139577)
25. Pai, R., Szabo, I.L., Kawanaka, H., Soreghan, B.A., Jones, M.K., and Tarnawski, A.S. (2000) Indomethacin inhibits endothelial cell proliferation by suppressing cell cycle proteins and PRB phosphorylation: A key to its antiangiogenic action? Mol. Cell Biol. Res. Commun. 4, 111-116 (Pubitemid 32183172)
26. Miternique-Grosse, A., Griffon, C., Siegel, L., Neuville, A., Weltin, D., and Stephan, D. (2006) Antiangiogenic effects of spironolactone and other potassium-sparing diuretics in human umbilical vein endothelial cells and in fibrin gel chambers implanted in rats. J. Hypertens. 24, 2207-2213 (Pubitemid 44611030)
27. Klint, P. and Claesson-Welsh, L. (1999) Signal transduction by fibroblast growth factor receptors. Front Biosci. 15, D165-D177
28. Webber, C.A., Chen, Y.Y., Hehr, C.L., Johnston, J., and McFarlane, S. (2005) Multiple signaling pathways regulate FGF-2-induced retinal ganglion cell neurite extension and growth cone guidance. Mol. Cell Neurosci. 30, 37-47 (Pubitemid 41133338)
29. Strniskova, M., Barancik, M., and Ravingerova, T. (2002) Mitogen-activated protein kinases and their role in regulation of cellular processes. Gen. Physiol. Biophys. 21, 231-255 (Pubitemid 35282663)
30. Fromigue, O., Hamidouche, Z., and Marie, P.J. (2008) Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J. Biol. Chem. 283, 30549-30556
31. Gross, N.D., Boyle, J.O., Du, B., Kekatpure, V.D., Lantowski, A., Thaler, H.T., Weksler, B.B., Subbaramaiah, K., and Dannenberg, A.J. (2007) Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma. Clin. Cancer Res. 13, 5901-5907
32. Guma, M., Rius, J., Duong-Polk, K.X., Haddad, G.G., Lindsey, J.D., and Karin, M. (2009) Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression. Proc. Natl Acad. Sci. USA 106, 8760-8765
33. Miura, S., Matsuo, Y., and Saku, K. (2008) Jun N-terminal kinase inhibitor blocks angiogenesis by blocking VEGF secretion and an MMP pathway. J. Atheroscler. Throm. 15, 69-74
34. Yoshino, Y., Aoyagi, M., Tamaki, M., Duan, L., Morimoto, T., and Ohno, K. (2006) Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells. Int. J. Oncol. 29, 981-987
35. Zhang, Z., Neiva, K.G., Lingen, M.W., Ellis, L.M., and Nor, J.E. (2010) VEGF-dependent tumor angiogenesis required inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ. 17, 499-512
36. Lin, A., Minden, A., Martinetto, H., Claret, F.X., Lange-Carter, C., Mercurio, F., Johnson, G.L., and Karin, M. (1995) Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268, 286-290
37. Fleming, Y., Armstrong, C.G., Morrice, N., Paterson, A., Goedert, M., and Cohen, P. (2000) Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1.JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem. J. 352, 145-154